David Georges
Director of Finance/CFO chez CELYAD ONCOLOGY SA
Profil
David Georges is currently the Vice President-Finance & Administration at Celyad Oncology SA. Previously, he worked as the Director-Finance & Administration at DIAsource ImmunoAssays SA and as a Financial Manager at Merck KGaA.
Mr. Georges completed his undergraduate degree at Université Catholique de Louvain.
Postes actifs de David Georges
Sociétés | Poste | Début |
---|---|---|
CELYAD ONCOLOGY SA | Director of Finance/CFO | 01/01/2019 |
Anciens postes connus de David Georges
Sociétés | Poste | Fin |
---|---|---|
MERCK KGAA | Corporate Officer/Principal | - |
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Director of Finance/CFO | - |
Formation de David Georges
Université Catholique de Louvain | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MERCK KGAA | Health Technology |
CELYAD ONCOLOGY SA | Health Technology |
Entreprise privées | 1 |
---|---|
DIAsource ImmunoAssays SA
DIAsource ImmunoAssays SA BiotechnologyHealth Technology DIAsource ImmunoAssays SA manufactures and distributes clinical diagnostics products. It develops, manufactures and markets clinical diagnostic products in the field of endocrinology and infectious diseases. The firm offer Elisa reader, washer and shaker, along with open and closed fully automated Elisa platforms helping customers to automate their tests. The company was founded in 1996 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |